AIMC Topic: CD13 Antigens

Clear Filters Showing 1 to 1 of 1 articles

In silico design of novel aptamers utilizing a hybrid method of machine learning and genetic algorithm.

Molecular diversity
Aptamers can be regarded as efficient substitutes for monoclonal antibodies in many diagnostic and therapeutic applications. Due to the tedious and prohibitive nature of SELEX (systematic evolution of ligands by exponential enrichment), the in silico...